科创创新药ETF（589720）涨超1%，924行情以来科创新药指数跑赢主要港股创新药指数

Group 1 - The ETF focuses on innovative drug companies listed on the Sci-Tech Innovation Board, tracking a representative index of 30 high-quality companies [1] - Since the "924 market" rally, the Sci-Tech Innovation Drug Index has outperformed major Hong Kong innovation drug indices, with returns of 75% compared to 70% for both Hong Kong innovation drug indices during the rebound period from September 24, 2024, to June 30, 2025 [1] - The product's 20% limit on daily price fluctuations aligns it more closely with the volatility of the sector, potentially allowing better participation in the Sci-Tech Board's resilience when market risk appetite increases [1]